[1]游丽娇,孙芳园,杨小芳,等.重楼皂苷Ⅱ对人非小细胞肺癌A549细胞凋亡的影响[J].中国中医药信息杂志,2021,28(10):81-85.[doi:10.19879/j.cnki.1005-5304.202103001]
 YOU Lijiao,SUN Fangyuan,YANG Xiaofang,et al.Effects of Polyphyllin on Apoptosis of Human Non-Small Cell Lung Cancer A549 Cells[J].zhongguo zhongyiyao xinxi zazhi,2021,28(10):81-85.[doi:10.19879/j.cnki.1005-5304.202103001]
点击复制

重楼皂苷Ⅱ对人非小细胞肺癌A549细胞凋亡的影响

参考文献/References:

[1] BRAY F, FERLAY J, SOERJOMATARAMoer I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424.

[2] YU H, KIM Y M, CHO M. Cytoplasm-localized SIRT1 downregulation attenuates apoptosis and cell cycle arrest in cisplatin-resistant lung cancer A549 cells[J]. J Cancer,2020,11(15):4495-4509.

[3] LIU F Y, PEI S H, LI W Q, et al. Characterization of formononetin sulfonation in SULT1A3 overexpressing HKE293 cells:involvement of multidrug resistance-associated protein 4 in excretion of sulfate[J]. Frontiers in Pharmacology,2021.https://doi.org/10. 3389/fphar.2020.614756.

[4] NIU H T, LIU Y, WANG Y Z, et al. Columbamine-mediated PTEN/AKT signal pathway regulates the progression of glioma[J]. Cancer Management and Research,2021,13:489-497.

[5] TEMIZ E, KOYUNCU L, SAHIN E. CCT3 suppression prompts apoptotic machinery through oxidative stress and energy deprivation in breast and prostate cancers[J]. Free Radic Biol Med,2021,165:88-99.

[6] 刘洁,胡晶,戴娜,等.益气解毒方主要三萜类化合物抑制鼻咽癌CNE2细胞增殖效应的比较[J].湖南中医药大学学报,2019,39(11):1315-1320.

[7] 喻青青,樊旭,朱敏,等.重楼皂苷Ⅰ抗肝癌细胞作用的初步研究[J].中国免疫学杂志,2021,37(1):57-60.

[8] NIU W, XU L, LI J, et al. Polyphyllin Ⅱ inhibits human bladder cancer migration and invasion by regulating EMT-associated factors and MMPs[J]. Oncology Letters,2020,20(3):2928-2936.

[9] PANNG D J, YANG C C, LI C, et al. Polyphyllin Ⅱ inhibits liver cancer cell proliferation, migration and invasion through downregulated cofilin activity and the AKT/NF-κB pathway[J]. Biology Open,2020,9(2):bio046854.

[10] LIU F, ZHANG L, LI F, et al. A noteworthy interface-targeting fluorescent probe for long-term tracking mitochondria and visualizing mitophagy[J]. Biosens Bioelectron,2020,168:112526.

[11] BAGKOS G, KOUFOPOULOS K, PIPERI C. A new model for mitochondrial membrane potential production and storage[J]. Medical Hypotheses, 2014,83(2):175-181.

[12] WYRSCH P, BLENN C, PESCH T, et al. Cytosolic Ca2+ shifts as early markers of cytotoxicity[J]. Cell Commun Signal,2013.https:// doi.org/10.1186/1478-811X-11-11.

[13] YANG Y, YANG X L, LI L, et al. LASS2 inhibits proliferation and induces apoptosis in HepG2 cells by affecting mitochondrial dynamics, the cell cycle and the nuclear factor?/span>κB pathways[J]. Oncol Rep,2019,41(5):3005-3014.

[14] MAILLET A, YADAV S, LOO Y L, et al. A novel osmium-based compound targets the mitochondria and triggers ROS-dependent apoptosis in colon carcinoma[J]. Cell Death Dis,2013,4:e653.

[15] CHENG M H, HUANG H L, LIN Y Y, et al. BA6 induces apoptosis via stimulation of reactive oxygen species and inhibition of oxidative phosphorylation in human lung cancer cells[J]. Oxid Med Cell Longev,2019,2019:6342104.

[16] KUZNETSOV A V, JAVADOV S, SAKS V, et al. Synchronism in mitochondrial ROS flashes, membrane depolarization and calcium sparks in human carcinoma cells[J]. Biochim Biophys Acta Bioenerg,2017,1858(6):418-431.

[17] O’NEILL K L, HUANG K, ZHANG J J, et al. Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane[J]. Genes & Development,2016,30:973-988.

[18] RAGHAV P K, KUMAR R, KUMAR V, et al. Docking-based approach for identification of mutations that disrupt binding between Bcl-2 and Bax proteins:inducing apoptosis in cancer cells[J]. Mol Genet Genomic Med,2019,7(11):e910.

相似文献/References:

[1]杨国旺,富琦,徐咏梅,等.晚期非小细胞肺癌患者凝血指标的临床分析[J].中国中医药信息杂志,2009,16(6):19.
 YANG Guo-wang,FU Qi,XU Yong-mei,et al.Clinical Analysis on Coagulation Markers in Advanced NSCLC Patients[J].zhongguo zhongyiyao xinxi zazhi,2009,16(10):19.
[2]周雍明,朴炳奎,侯炜,等.肺瘤平膏改善非小细胞肺癌患者免疫状态及预后的临床观察[J].中国中医药信息杂志,2008,15(5):78.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(10):78.
[3]宋翠萍.艾迪注射液联合化疗治疗晚期非小细胞肺癌临床观察[J].中国中医药信息杂志,2008,15(7):64.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(10):64.
[4]刘秀芳,李凤玉,王炳胜,等.益气活血中药对肺癌放疗患者肺功能的影响[J].中国中医药信息杂志,2008,15(8):16.
 LIU Xiu-fang,LI Feng-yu,WANG Bing-sheng,et al.Effect of Yiqi Huoxue Recipe on Pulmonary Function of Lung Cancer Patients after Radiation Therapy[J].zhongguo zhongyiyao xinxi zazhi,2008,15(10):16.
[5]张培新,陈坤,王春雨.复方苦参注射液联合化疗治疗中晚期非小细胞肺癌50例[J].中国中医药信息杂志,2008,15(8):63.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(10):63.
[6]杨宗艳,林洪生,李道睿.单纯中药和单药化疗治疗老年晚期非小细胞肺癌临床研究[J].中国中医药信息杂志,2008,15(8):79.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(10):79.
[7]龚志敏,王言,余川运,等.参芪扶正注射液配合NP方案化疗治疗老年晚期非小细胞肺癌疗效观察[J].中国中医药信息杂志,2008,15(9):64.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(10):64.
[8]解建国,阳其绢,何丰华,等.肺癌1号方对晚期非小细胞肺癌患者免疫功能及血清VEGF、CYFRA21-1的影响[J].中国中医药信息杂志,2008,15(11):9.
 XIE Jian-guo,YANG Qi-juan,HE Feng-hua,et al.Effect of Lung Cancer Fang No.1 on Immune Function and Serum VEGF, CYFRA21-1 in Advanced Non-Small Cell Lung Cancer Patients[J].zhongguo zhongyiyao xinxi zazhi,2008,15(10):9.
[9]庄炜,李莉,湛韬,等.康艾注射液联合TP化疗方案治疗非小细胞肺癌的Meta分析[J].中国中医药信息杂志,2011,18(5):29.[doi:10.3969/j.issn.1005-5304.2011.05.011]
 ZHUANG Wei,LI Li,ZHAN Tao,et al.Meta-analysis of Kang Ai Injection Together with TP Model Chemotherapy for Treatment of Non-small Cell Lung Cancer[J].zhongguo zhongyiyao xinxi zazhi,2011,18(10):29.[doi:10.3969/j.issn.1005-5304.2011.05.011]
[10]冯利,花宝金,朴炳奎.肺瘤平Ⅱ号改善肺癌患者生存质量临床研究[J].中国中医药信息杂志,2006,13(12):12.
 FENG Li,HUA Bao-Jin,PIAO Bing-Kui.Clinical Study of Feiliuping Ⅱ on Quality of Life of Lung Cancer Patients[J].zhongguo zhongyiyao xinxi zazhi,2006,13(10):12.

备注/Memo

基金项目:国家自然科学基金面上项目(81973649);浦东新区卫生健康委员会领先人才培养项目(pwr12019-02);浦东新区卫生健康委员会学科建设项目(PWZy2020-07);浦东新区卫生健康委员会临床高原学科建设计划(PWYgy2018-01)

更新日期/Last Update:

2021-09-22